Institut für Molekulare Immunologie, Helmholtz-Zentrum München, Marchioninistr. 25, 81377, Munich, Germany.
Cancer Immunol Immunother. 2014 May;63(5):491-9. doi: 10.1007/s00262-014-1538-7. Epub 2014 Mar 18.
Costimulatory surface molecules and instructive cytokines expressed by dendritic cells (DCs) determine the outcome of an immune response. In malignant disease, DCs are often functionally compromised. In most tumors studied so far, the deficient induction of effective T cell responses has been associated with a blockade of DC maturation, but little has been known on DCs infiltrating malignant B cell lymphoma. Here, we investigated for the first time the phenotypic and functional status of DCs in B cell lymphoma, and we analyzed the network of DCs, tumor cells, natural killer (NK) cells and cytokines present in the tumor micromilieu. Therefor, we used an endogenous myc-transgenic mouse lymphoma model, because transplanted tumor cells foster an IFN-γ-driven Th1 antitumor response rather than an immunosuppressive environment, which is observed in autochthonous neoplasias. Lymphoma-infiltrating DCs showed a mature phenotype and a Th2-inducing cytokine pattern. This situation is in contrast to most human malignancies and mouse models described. Cellular contacts between DCs and tumor cells, which involved CD62L on the lymphoma, caused upregulation of costimulatory molecules, whereas IL-10 primarily derived from lymphoma cells induced an IL-12/IL-10 shift in DCs. Thus, alteration of costimulatory molecules and instructive cytokines was mediated by distinct mechanisms. Normal NK cells were able to additionally modulate DC maturation but this effect was absent in the lymphoma environment where IFN-γ production by NK cells was severely impaired. These data are relevant for establishing novel immunotherapeutic approaches against B cell lymphoma.
树突状细胞 (DCs) 表面表达的共刺激分子和指导细胞因子决定了免疫反应的结果。在恶性疾病中,DC 通常功能受损。在迄今为止研究的大多数肿瘤中,有效的 T 细胞反应诱导不足与 DC 成熟受阻有关,但对浸润恶性 B 细胞淋巴瘤的 DC 知之甚少。在这里,我们首次研究了 B 细胞淋巴瘤中 DC 的表型和功能状态,并分析了肿瘤微环境中存在的 DC 网络、肿瘤细胞、自然杀伤 (NK) 细胞和细胞因子。为此,我们使用了内源性 myc 转基因小鼠淋巴瘤模型,因为移植的肿瘤细胞促进了 IFN-γ 驱动的 Th1 抗肿瘤反应,而不是在自发肿瘤中观察到的免疫抑制环境。浸润性淋巴瘤的 DC 表现出成熟的表型和 Th2 诱导细胞因子模式。这种情况与大多数人类恶性肿瘤和描述的小鼠模型形成对比。DC 与肿瘤细胞之间的细胞接触,涉及淋巴瘤中的 CD62L,导致共刺激分子上调,而主要来自淋巴瘤细胞的 IL-10 诱导 DC 中 IL-12/IL-10 转移。因此,共刺激分子和指导细胞因子的改变是由不同的机制介导的。正常 NK 细胞能够进一步调节 DC 成熟,但在 NK 细胞 IFN-γ产生严重受损的淋巴瘤环境中,这种效应不存在。这些数据对于建立针对 B 细胞淋巴瘤的新型免疫治疗方法具有重要意义。